NK and B cell deficiency in a MPS type II family with novel mutation in the IDS gene

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorTORRES, Leuridan Cavalcante
dc.contributor.authorSOARES, Diogo Cordeiro de Queiroz
dc.contributor.authorKULIKOWSKI, Leslie Domenici
dc.contributor.authorFRANCO, Jose Francisco
dc.contributor.authorKIM, Chong Ae
dc.date.accessioned2015-02-06T19:45:53Z
dc.date.available2015-02-06T19:45:53Z
dc.date.issued2014
dc.description.abstractThe mucopolysaccharidoses (MPSs) are a group of rare, inherited lysosomal storage disorders that are clinically characterized by abnormalities in multiple organ systems and reduced life expectancy. Whereas the lysosome is essential to the functioning of the immune system, some authors suggest that the MPS patients have abnormalities in the immune system similar to the patients with primary immunodeficiency. In this study, we evaluated 8 male MPS type II patients of the same family with novel mutation in the IDS gene. We found in this MPS family a quantitative deficiency of NK and B cells with normal values of IgG, IgM and IgA serum antibodies and normal response to polysaccharide antigens. Interestingly, abnormalities found in these patients were not observed in other MPS patients, suggesting that the type of mutation found in the IDS gene can be implicated in the immunodeficiency.
dc.description.indexMEDLINE
dc.description.sponsorshipSao Paulo Research Foundation (FAPESP) [2010/52694-8]
dc.identifier.citationCLINICAL IMMUNOLOGY, v.154, n.2, p.100-104, 2014
dc.identifier.doi10.1016/j.clim.2014.07.001
dc.identifier.eissn1521-7035
dc.identifier.issn1521-6616
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/8560
dc.language.isoeng
dc.publisherACADEMIC PRESS INC ELSEVIER SCIENCE
dc.relation.ispartofClinical Immunology
dc.rightsrestrictedAccess
dc.rights.holderCopyright ACADEMIC PRESS INC ELSEVIER SCIENCE
dc.subjectMucopolysaccharidoses
dc.subjectNK cells
dc.subjectB cells
dc.subjectImmunodeficiency
dc.subjectAutoimmunity
dc.subject.othernatural-killer-cells
dc.subject.otherintracellular pathogens
dc.subject.otherantigen presentation
dc.subject.othersecretory lysosomes
dc.subject.otheradaptive immunity
dc.subject.otherhunter-syndrome
dc.subject.othert-cells
dc.subject.otherikaros
dc.subject.otherspecificity
dc.subject.otheractivation
dc.subject.wosImmunology
dc.titleNK and B cell deficiency in a MPS type II family with novel mutation in the IDS gene
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.citation.scopus4
hcfmusp.contributor.author-fmusphcLEURIDAN CAVALCANTE TORRES
hcfmusp.contributor.author-fmusphcDIOGO CORDEIRO DE QUEIROZ SOARES
hcfmusp.contributor.author-fmusphcLESLIE DOMENICI KULIKOWSKI
hcfmusp.contributor.author-fmusphcJOSE FRANCISCO DA SILVA FRANCO
hcfmusp.contributor.author-fmusphcCHONG AE KIM
hcfmusp.description.beginpage100
hcfmusp.description.endpage104
hcfmusp.description.issue2
hcfmusp.description.volume154
hcfmusp.origemWOS
hcfmusp.origem.scopus2-s2.0-84905247508
hcfmusp.origem.wosWOS:000341959300002
hcfmusp.publisher.citySAN DIEGO
hcfmusp.publisher.countryUSA
hcfmusp.relation.referenceAraya K, 2009, MOL GENET METAB, V98, P255, DOI 10.1016/j.ymgme.2009.05.006
hcfmusp.relation.referenceBiron CA, 2010, NAT IMMUNOL, V11, P1080, DOI 10.1038/ni1210-1080
hcfmusp.relation.referenceBlanca IR, 2001, J IMMUNOL, V167, P6132
hcfmusp.relation.referenceBlott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732
hcfmusp.relation.referenceBryceson YT, 2008, CURR OPIN IMMUNOL, V20, P344, DOI 10.1016/j.coi.2008.03.005
hcfmusp.relation.referenceCerwenka A, 2001, IMMUNOL REV, V181, P158, DOI 10.1034/j.1600-065X.2001.1810113.x
hcfmusp.relation.referenceCLEVERS HC, 1993, IMMUNOL TODAY, V14, P591, DOI 10.1016/0167-5699(93)90198-T
hcfmusp.relation.referenceDi Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700
hcfmusp.relation.referenceFlodstrom-Tullberg M, 2009, CURR OPIN IMMUNOL, V21, P634, DOI 10.1016/j.coi.2009.09.012
hcfmusp.relation.referenceGEORGOPOULOS K, 1992, MOL CELL BIOL, V12, P747
hcfmusp.relation.referenceGEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3
hcfmusp.relation.referenceGEORGOPOULOS K, 1992, SCIENCE, V258, P808, DOI 10.1126/science.1439790
hcfmusp.relation.referenceGregoire C, 2007, IMMUNOL REV, V220, P169, DOI 10.1111/j.1600-065X.2007.00563.x
hcfmusp.relation.referenceHesslein DGT, 2011, ADV IMMUNOL, V109, P45, DOI 10.1016/B978-0-12-387664-5.00002-9
hcfmusp.relation.referenceHolt OJ, 2006, J BIOCHEM, V140, P7, DOI 10.1093/jb/mvj126
hcfmusp.relation.referenceHsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x
hcfmusp.relation.referenceKato T, 2005, J HUM GENET, V50, P395, DOI 10.1007/s10038-005-0266-4
hcfmusp.relation.referenceKirstetter P, 2002, EUR J IMMUNOL, V32, P720, DOI 10.1002/1521-4141(200203)32:3<720::AID-IMMU720>3.0.CO;2-P
hcfmusp.relation.referenceKolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743
hcfmusp.relation.referenceLanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581
hcfmusp.relation.referenceLi P, 2005, IMMUNOL REV, V207, P206, DOI 10.1111/j.0105-2896.2005.00297.x
hcfmusp.relation.referenceMartin R, 2008, PEDIATRICS, V121, pE377, DOI 10.1542/peds.2007-1350
hcfmusp.relation.referenceMor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723
hcfmusp.relation.referenceMoraes-Pinto M.I., 2006, IMMUNODEFIC DISORD, V3, P1
hcfmusp.relation.referenceMuenzer J, 2009, PEDIATRICS, V124, pE1228, DOI 10.1542/peds.2008-0999
hcfmusp.relation.referenceMuenzer J, 2004, J PEDIATR, V144, pS27, DOI 10.1016/j.jpeds.2004.01.052
hcfmusp.relation.referenceNg S, 2011, NEW ENGL J MED, V364, P586, DOI 10.1056/NEJMc1012485
hcfmusp.relation.referenceOrange JS, 2006, CLIN IMMUNOL, V118, P1, DOI 10.1016/j.clin.2005.10.011
hcfmusp.relation.referenceQuaio CRDC, 2012, JIMD REP, V4, P125, DOI 10.1007/8904_2011_90
hcfmusp.relation.referenceRadoja S, 2006, CRIT REV IMMUNOL, V26, P265
hcfmusp.relation.referenceSchmid D, 2005, CELL DEATH DIFFER, V12, P1519, DOI 10.1038/sj.cdd.4401727
hcfmusp.relation.referenceSchmid D, 2006, J MOL MED-JMM, V84, P194, DOI 10.1007/s00109-005-0014-4
hcfmusp.relation.referenceSun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044
hcfmusp.relation.referenceVivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582
hcfmusp.relation.referencevon Bubnoff D, 2010, J ALLERGY CLIN IMMUN, V125, P60, DOI 10.1016/j.jaci.2009.11.020
hcfmusp.relation.referenceZingoni A, 2004, J IMMUNOL, V173, P3716
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication32955c02-b35a-4dd6-afce-2e2b08acf519
relation.isAuthorOfPublication32df8f1a-969e-43b6-8e78-25d3cc08b666
relation.isAuthorOfPublicationa248ef47-b0c3-4941-ba03-78adb1cf4766
relation.isAuthorOfPublicationde4bab2f-17f6-40db-84ab-1c89919a45ea
relation.isAuthorOfPublication8715370a-1e5f-4af6-a1c4-ee31748e12a3
relation.isAuthorOfPublication.latestForDiscovery32955c02-b35a-4dd6-afce-2e2b08acf519
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_TORRES_NK_and_B_cell_deficiency_in_a_MPS_2014.PDF
Tamanho:
613.43 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)